WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience MBF Stereo Investigator
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, November 5, 2003, 23(31):10146-10153

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ray, A. M.
Right arrow Articles by Davies, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ray, A. M.
Right arrow Articles by Davies, C. H.

 Previous Article  |  Next Article 

Cellular/Molecular
Capsazepine Protects against Neuronal Injury Caused by Oxygen Glucose Deprivation by Inhibiting Ih

Alison M. Ray, Ceri D. Benham, Jenny C. Roberts, Catherine H. Gill, Christophe Lanneau, Danniel P. Gitterman, Mark Harries, John B. Davis, and Christopher H. Davies

Neurology Centre of Excellence for Drug Discovery, GlaxoSmithKline, Harlow, Essex, CM19 5AW, United Kingdom

Cell death mechanisms frequently involve the influx of extracellular calcium through voltage- and ligand-gated ion channels, e.g., the NMDA receptor (Greene, 1999). The vanilloid receptor (VR1) is present in regions of the brain (Mezey et al., 2000) that are highly susceptible to neurodegenerative insults, suggesting that this ion channel might contribute to the cellular processes involved in neuronal death. We tested the effects of VR1 ligands in the oxygen glucose deprivation (OGD) model of cell death in organotypic hippocampal slice cultures. The VR1 agonist capsaicin at concentrations that are selective for VR1 did not affect cell viability per se or the extent of neurodegeneration induced by the OGD insult. In contrast, the VR1 antagonist capsazepine (0.1-10 µM) significantly reduced the amount of OGD-induced cell death. However, capsazepine was still neuroprotective in slices prepared from VR1 knock-out mice, which exhibited the same degree of neurodegeneration to that observed in slices prepared from wild-type mice, excluding the possibility that it afforded neuroprotection through inhibition of VR1. Instead, capsazepine inhibited the hyperpolarization-activated nonspecific cation channel generated current Ih in a concentration range similar to that which was neuroprotective. Furthermore, the specific Ih blocker ZD-7288 was also neuroprotective, mirroring the effects of capsazepine, in that it was effective at preventing cell death when applied either during or after the OGD insult. These results demonstrate that capsazepine affords neuroprotection through inhibition of Ih rather than inhibition of VR1.

Key words: capsazepine; vanilloid; organotypic slice; neuroprotection; oxygen/glucose deprivation; HCN channels; Ih


Received July 2, 2003; revised July 2, 2003; accepted September 10, 2003.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-C. Lin, H.-W. Uang, R.-J. Lin, I.-J. Chen, and Y.-C. Lo
Neuroprotective Effects of Glyceryl Nonivamide against Microglia-Like Cells and 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Human Dopaminergic Neuroblastoma Cells
J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 877 - 887.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
I. Shimizu, T. Iida, N. Horiuchi, and M. J. Caterina
5-Iodoresiniferatoxin Evokes Hypothermia in Mice and Is a Partial Transient Receptor Potential Vanilloid 1 Agonist in Vitro
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1378 - 1385.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. R. Kim, D. Y. Lee, E. S. Chung, U. T. Oh, S. U. Kim, and B. K. Jin
Transient Receptor Potential Vanilloid Subtype 1 Mediates Cell Death of Mesencephalic Dopaminergic Neurons In Vivo and In Vitro
J. Neurosci., January 19, 2005; 25(3): 662 - 671.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. Zhang and G. J. Barritt
Evidence that TRPM8 Is an Androgen-Dependent Ca2+ Channel Required for the Survival of Prostate Cancer Cells
Cancer Res., November 15, 2004; 64(22): 8365 - 8373.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Yamamura, S. Ugawa, T. Ueda, M. Nagao, and S. Shimada
Capsazepine Is a Novel Activator of the {delta} Subunit of the Human Epithelial Na+ Channel
J. Biol. Chem., October 22, 2004; 279(43): 44483 - 44489.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
P. Pacher, S. Batkai, and G. Kunos
Haemodynamic profile and responsiveness to anandamide of TRPV1 receptor knock-out mice
J. Physiol., July 15, 2004; 558(2): 647 - 657.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-